what is going on with tirzepatide Semaglutide vs. for Weight Loss Tirzepatide, a New Era of

Weight-loss drugs are dominating conversations right now, from Ozempic and Wegovy to Zepbound and Mounjaro

Impact of GLP-1 receptor agonist-based therapies on cardiovascular and renal outcomes in diabetic and non-diabetic patients with CKD

They are medications that need to be rightly prescribed by a doctor who is experienced in the management of insulin resistance and type 2 diabetes. Wegovy and Saxenda have been approved by the TGA for weight management in people with obesity or those considered overweight with at least one weight-related comorbidity

This causes rapid fluid absorption into the intestines from the intravascular space, decreasing circulating blood volume and increasing digestive peptide hormone and vasoactive hormone release

Study 7 was a 64-week trial that enrolled 307 patients with obesity (BMI greater than or equal to 30 kg/m2) or with overweight (BMI 27-29.9 kg/m2) and at least one weight-related comorbid condition, such as treated or untreated dyslipidemia or hypertension